Similar articles

• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.

  Fillit H, Nash DT, Shineman D. Fillit H, et al. Alzheimers Dement. 2009 Mar;5(2):149-53. doi: 10.1016/j.jalz.2009.01.012. Alzheimers Dement. 2009. PMID: 19328448 No abstract available.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.

  Korczyn AD. Korczyn AD. Alzheimers Dement. 2009 Mar;5(2):157-8. doi: 10.1016/j.jalz.2009.01.009. Alzheimers Dement. 2009. PMID: 19328450 No abstract available.
• Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases.

  Snyder PJ. Snyder PJ. Alzheimers Dement. 2010 Mar;6(2):135-7. doi: 10.1016/j.jalz.2010.01.007. Alzheimers Dement. 2010. PMID: 20298974
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.

  Petanceska S, Ryan L, Silverberg N, Buckholtz N. Petanceska S, et al. Alzheimers Dement. 2009 Mar;5(2):130-2. doi: 10.1016/j.jalz.2009.01.014. Alzheimers Dement. 2009. PMID: 19328442 Review. No abstract available.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.

  Schneider LS. Schneider LS. Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023. Alzheimers Dement. 2009. PMID: 19328454 Review. No abstract available.